G-protein-coupled receptors (GPCRs) are the most abundant cellsurface receptor proteins, important for virtually all physiological processes. As major targets for treatment of disease, understanding GPCR structure and how this relates to their function is critically important for optimal exploitation of their therapeutic potential 1 . GPCRs allosterically transmit extracellular signals to the inside of cells by forming complexes with transducers, such as G proteins or arrestins 2 . To date, crystal structures of around 40 inactive class A GPCRs (of more than 800 encoded in the human genome) have been solved, with most being engineered to improve stability in detergents and/or crystal packing 3 . Far fewer agonist-bound GPCR structures have been determined, and only one in complex with a full heterotrimeric Gα β γ protein 4 . Transmembrane domain structures of class B GPCRs have been especially refractory to crystallization and are currently limited to two inactive state structures 5-7 , with no reported full-length class B GPCR structures, to our knowledge.
Structure determination
To enable efficient expression and purification, the CTR was modified to replace the native signal peptide with haemagglutinin (HA), followed by a Flag epitope for affinity purification and an HRV 3C cleavage site, while the C terminus was modified by the addition of an HRV 3C cleavage site and histidine affinity tag (Extended Data Fig. 1 ). These modifications had no effect on receptor pharmacology (Extended Data Fig. 2 ).
To form an active, G-protein-coupled complex, the CTR was coexpressed with Gα s , His-Gβ 1 , and Gγ 2 in HighFive insect cells and stimulated with an excess of the high-affinity agonist, salmon calcitonin (sCT) that has a very slow off-rate 16, 17 . The complex was solubilized in MNG/cholesteryl hemisuccinate and purified using an anti-Flag antibody affinity column and size-exclusion chromatography (SEC) (Extended Data Fig. 3 ). Further complex stabilization was achieved with the addition of a camelid antibody, Nb35, which binds at the Gα s -Gβ interface and was used in the determination of the β 2 adrenergic receptor (β 2 AR)-G s heterotrimer structure 4 . Addition of purified Nb35 to insect cell membranes expressing CTR, Gα s and β γ before purification produced a monodispersed complex by SEC that remained stable at 4 °C for at least 5 days; however, as noted for the β 2 AR-G s complex, the G s heterotrimer could no longer bind to GTPγ S (Extended Data Figs 2e and 3e).
We recorded images of frozen-hydrated sCT-CTR-G s complex using Volta phase-plate cryo-EM, obtaining particle projections with high Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, such as osteoporosis, diabetes and obesity. Here we report the structure of a full-length class B receptor, the calcitonin receptor, in complex with peptide ligand and heterotrimeric Gα s βγ protein determined by Volta phase-plate single-particle cryo-electron microscopy. The peptide agonist engages the receptor by binding to an extended hydrophobic pocket facilitated by the large outward movement of the extracellular ends of transmembrane helices 6 and 7. This conformation is accompanied by a 60° kink in helix 6 and a large outward movement of the intracellular end of this helix, opening the bundle to accommodate interactions with the α5-helix of Gα s . Also observed is an extended intracellular helix 8 that contributes to both receptor stability and functional G-protein coupling via an interaction with the Gβ subunit. This structure provides a new framework for understanding G-protein-coupled receptor function.
contrast (Extended Data Fig. 4 ). 2D classification revealed averages with secondary structure features and sufficient distribution in orientation of particles to enable reconstructions. 3D classification with Relion 18 facilitated the selection of about 106,000 particle projections, which were used to obtain a cryo-EM density map with a nomi nal global resolution of 4.1 Å, and 3.8 Å resolution at the interaction between the transmembrane region of CTR and G s (Fig. 1 , Extended Data Fig. 4 ).
The cryo-EM map allows for near-atomic interpretation of the regions of the complex corresponding to the G s protein and nanobody and transmembrane helix bundle. An additional density, tightly inserted within an opening of the helical bundle and attributable to sCT is also resolved (Fig. 1a ). The ECD is less well resolved owing to partial flexibility, while large variability in the Gα s α -helical domain (AHD) prevented reconstruction of this density (Extended Data Fig. 5 ). The AHD domain is discernible in low-resolution 3D maps, where it is observed to adopt variable conformations in respect to the Ras-like domain, consistent with previous studies on the β 2 AR-G s heterotrimer complex 19 and light-activated rhodopsin complexed with G i 20 . This is interesting in the context of the CTR where two agonists, human and salmon calcitonin, promote ternary complexes with distinct G-protein conformations that exhibit different nucleotide affinities and have distinct efficacies 17 . The conformational heterogeneity of the sCT-CTRcomplexed Gα s suggests that this may contribute to these observations.
We also observed multiple conformations of the receptor N-terminal ECD relative to the transmembrane core (Extended Data Fig. 5 ), indicating that, for the peptide-agonist-bound CTR, this domain remains flexible. This flexibility is likely to be important as modifications to sCT that extend secondary structure are detrimental to affinity and potency 21 . In the cryo-EM structure, the density corresponding to the ECD is lower in resolution than the rest of the complex (Extended Data Fig. 4d ). Although this did not permit accurate modelling, there was strong agreement with the isolated ECD/sCT structure (Protein Data Bank (PDB) accession: 5II0) 22 that could be fit to the density, contiguous with transmembrane domain 1 (TM1) (Extended Data Fig. 6a ). There is also additional density in the ECD around residue 130, corresponding to predicted glycosylation in this region. As previously described 23 , mutation of either Asn125 or Asn130 to Asp was detrimental to sCT affinity and function, suggesting that this glycosylation is required for normal agonist activity (Extended Data Fig. 6 ).
Structure of the activated CTR transmembrane bundle
The transmembrane bundle and the G-protein complex (minus the Gα s AHD) were resolved at a nominal resolution of 3.8 Å, with the quality of the cryo-EM density map highest within the G protein and at the Gα s -receptor interface. The local resolution varied within the CTR transmembrane bundle (Extended Data Fig. 4 ) with weaker density in the extracellular loops (ECLs), intracellular loops (ICLs), and the top of TM6. The limited resolution of the map in these regions suggests local flexibility that is probably required for receptor function. The CTR contains a very long extended helix 8, similar to that observed in the inactive state glucagon receptor (GCGR) structure 7 , implying that this may be a general feature for class B GPCRs. While the remaining CTR C terminus beyond helix 8 was present in the protein, it is not visible in the cryo-EM map, suggesting that this region remains mobile when the receptor is bound to a G protein.
sCT density indicates that the depth of the CTR orthosteric binding site (Figs 1 and 2a) is shallower than that predicted for some class B GPCRs 7, 24, 25 , with the N terminus residing approximately one helical turn above a network of conserved class B polar residues. Limited density was observed for sCT side chains, making peptide modelling ambiguous. Although specific interactions could not be identified, sCT is likely to form extensive contacts with the tops of all transmembrane domains (with the exception of TM4), as well as ECL2. The N terminus of the calcitonin family of peptides is distinct from that of other orthosteric class B GPCR peptide ligands, with a cyclized N terminus formed by a disulfide bond between residues 1 and 7. The apparent outward movements of TM6 and TM7 (relative to inactive structures, as discussed below) appear crucial to accommodate the peptide N terminus ( Fig. 2a ).
Although there are multiple possible modelling solutions for sCT, we have reported the most parsimonious, taking into account the cryo-EM map and experimental data. This model predicts that sCT maintains helicity up to residue 6, forming an amphipathic helix with Val8, Leu12, Leu16 and Leu19 facing towards a hydrophobic receptor environment ( Fig. 2b ). This is in agreement with evidence that an amphipathic helix contributes to peptide activity 26 and consistent with that predicted from a solution NMR structure of sCT 27 . Gln14 is predicted to form hydrogen bond interactions with the ECL2 backbone, yet is in an orientation with solvent accessibility (Extended Data Fig. 7a ). This is an essential requirement as Gln14 can be directly labelled or replaced with a Lys to conjugate bulky substituents (radiolabels or fluorophores), while still maintaining peptide activity. In addition, two residues crucial for 
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agonist activity, Ser5 and Thr6, are predicted to interact with TM5, potentially forming polar interactions with His302 5.40b (superscript indicates class B GPCR numbering 29 ) (Extended Data Fig. 7b ). This model is supported by mutation of His302 5.40b to Ala that reduced sCT potency in cAMP production and ERK1/2 phosphorylation, consistent with reduced sCT affinity (Extended Data Fig. 7c ). The first three residues in sCT make minimal receptor contacts in this model, consistent with experimental data showing that these residues can be removed without altering peptide activity 28 .
Comparison of active CTR to inactive class B GPCR TMs
Comparison of the CTR complex with inactive class B GPCR structures (GCGR 6,7 and corticotropin-releasing hormone receptor 1 (CRF 1 R; ref. 5)) or inactive CTR homology models provides insight into transmembrane conformational transitions upon class B GPCR activation ( Fig. 3a , Extended Data Fig. 8 ). The most striking observations relate to TM6 where there is a large outward movement at the cytoplasmic face in the activated CTR (approximately 15 Å) relative to the inactive structures when measured from the Cα at X 6.35b . An outward movement within TM6, as well as disordering and unwinding of this helix was observed at the extracellular face (9-11 Å when measured from the Cα of Phe 5.56b ). This is correlated with an extremely sharp (around 60°) kink at the centre of TM6 formed around Pro 6.47b -X-X-Gly 6.50b . Importantly, residues within this motif influence agonist affinity, activation and function in both CTR and the related calcitonin receptor-like receptor 30, 31 . The very high conservation of the Pro 6.47b -X-X-Gly 6.50b motif in class B GPCRs (Supplementary Information Fig. 1 ) implies that these residues may be globally important for activation through the formation of a kink in TM6 that is much more pronounced than in any transmembrane helix in GPCR structures solved to date.
In comparison to both inactive structures, there is an inward movement at the top of TM1 in the CTR-G s structure and a small outward movement at the top of TM5. TM7 movement differs when comparing individual inactive structures to the CTR-G s complex (Fig. 3a ). While the TM7 kink angle is similar in the inactive CRF 1 R and the CTR, TM7 is shifted towards TM6 in the CTR. By contrast, there is a large, 9 Å outward movement in the top of TM7 in the CTR structure relative to the GCGR. While the differences observed in location of the top of transmembrane helices may represent physiologically relevant differences, we interpret them with caution because the inactive structures do not include the receptor ECDs. There is increasing evidence for a dynamic role of class B ECD-transmembrane-core interactions in receptor quiescence and activation [32] [33] [34] [35] and the large outward movement of helices 6 and 7 required for peptide binding support a model of class B GPCR quiescence where the tops of TM6 and TM7 are potentially constrained by ECL3 interactions with the far N-terminal ECD, a theory supported by experimental data on the glucagon receptor [32] [33] [34] . Nonetheless, in all structures, the top of TM6/ECL3 has a large degree of structural flexibility, supported by its weak corresponding density in the cryo-EM map of the CTR-G s complex (Extended Data Fig. 4d ) and the high crystallographic temperature factors exhibited by inactive structures in these regions 5, 7 .
Interactions in conserved residues
Class B GPCRs contain highly conserved transmembrane domain polar residues that have crucial roles in receptor integrity, highaffinity agonist interaction and/or receptor activation and downstream signalling 6, 7, 25, 29, [36] [37] [38] . A central polar network (Asn194 2.60b , Asn233 3.43b , Gln355 6.52b and Gln383 7.49b in the CTR) is present in all inactive structures [5] [6] [7] and in our inactive CTR homology model. This network is preserved in the active CTR transmembrane bundle, although the exact interactions and their relative strengths probably vary in the different structures ( Fig. 3b and Extended Data Fig. 8c ), in a receptor-and peptide-specific manner 25, 29 . Not predicted from previous studies, Tyr191 2.57b is also involved in this network. This residue is unique to the CTR, being a hydrophobic Phe in all other class B receptors ( Supplementary Fig. 1 ), suggesting receptor-specific differences in how the binding energy is translated through the protein to promote G-protein activation.
At the cytoplasmic face, an important interaction between His 2.50b and Glu 3.50b , considered to play an equivalent functional role in class B GPCRs to the DRY motif in class A GPCRs, is present in the inactive class B crystal structures [5] [6] [7] 29, 36 and is maintained in the active CTR transmembrane bundle ( Fig. 3b and Extended Data Fig. 8c ). These residues form an extensive polar interaction network with Thr 6.42b and Tyr 7.57b , locking the base of the receptor in an inactive conformation in our inactive CTR homology model, consistent with that of the two published GCGR inactive structures 6, 7 . In the CRF 1 R, these residues are further apart due to disruption by the thermostabilizing mutation Ala 7.57b and binding of the small-molecule antagonist 5 (Fig. 3b ). This network is broken in the CTR-G s structure, with Tyr 7.57b forming new hydrogen bond interactions with the TM6 backbone ( Fig. 3b and Extended Data Fig. 8c ). This releases constraints on TM6 and probably assists in the large conformational transition of TM6 away from the core of the bundle. Consistent with this, mutation of these residues either results in constitutive activation 36 or reduced receptor expression 29, 36 .
At the cytoplasmic face, Arg 2.46b , Arg/Lys 6.37b , Asn 7.61b and Glu 8.41b (TM2-6-7-H8 network) form tight interactions in the GCGR inactive structure and our CTR homology model with two key salt bridges formed by Glu 8.41b with Arg 2.46b and Arg/Lys 6.37b (Fig. 3b ). These interactions are not present in the inactive CRF 1 R owing to the absence of helix 8, but have been predicted in other class B GPCRs 36, 38 and are likely conserved across the entire family. While the interaction between Glu 8.41b and Arg 2.46b is likely maintained in the active CTR-Gs structure, the salt bridge between Lys 6.37b and Glu 8.41b is broken with these residues residing 26 Å apart (Fig. 3b ). The reordering of these side chains in the active structure releases ground state constraints on TM6.
The CTR-G s interface
Extensive interactions formed between the CTR and Gα s stabilize the active receptor conformation. The receptor-Gα s interface is formed by TM6  TM7   TM1   TM2  TM3   TM4   TM5   TM6  TM7   TM1   TM2   TM3   TM4   TM5   TM6   H8 Central polar network TM2-3-6-7 network TM2-6-7-H8 network 6 (Fig. 4a and Extended Data Fig. 9a ). Class B GPCRs all predominantly couple to Gα s and several of the CTR residues that form interactions with the Ras-like domain of Gα s are highly conserved and have been previously implicated in G-protein coupling 36, 37 .
The buried interface between the receptor and the Ras-like domain of Gα s is 2,031 Å 2 , while an interface of 663 Å 2 is also provided by the interaction of helix 8 of CTR with Gβ 1 . Notably, helix 8 is heavily buried within the detergent micelle, facilitated by bulky aromatic residues and additional polar charged residues that can interact with lipid/ detergent head groups ( Fig. 4b and Extended Data Fig. 9b ). Sequential deletions of the CTR C terminus support a role for helix 8 lipid interactions in receptor stability at the cell surface ( Fig. 4c ). While truncation after Trp413 (Δ 414) had no effect on receptor function, truncation after Trp406 (Δ 407) resulted in reduced cell-surface receptor expression. Further truncation (Δ 400) resulted in a greater reduction in cell-surface expression, highlighting lipid interactions with receptor residues Thr400-Trp413 as essential for receptor stability. In addition, Δ 407, but not Δ 414 significantly reduced sCT-mediated cAMP efficacy, with no further reduction by Δ 400, suggesting CTR-Gβ interactions between residues 407 and 413 also contribute to the efficiency of G s -mediated cAMP production ( Fig. 4c ). There is only limited density in this region of the map, however contacts would be predicted between the CTR Gln408 and Gβ backbone. While side chain density is limited, the positioning of Cα would orient Arg404 and Gln415 of the CTR towards Asp312 and Gln44 in Gβ , respectively. Nonetheless, these CTR residues have no effect on G s -mediated cAMP efficacy. Gβ has additional roles in signalling, therefore it is possible that interactions in this region may contribute to other aspects of CTR function. A region of 12 amino acids within helix 8 that includes at least one important Trp residue is required for efficient cell-surface localization of the related calcitonin-like receptor 39 . Owing to the presence of an extended α -helix in the inactive structure of the GCGR and the CTR, it is likely that this functional role of helix 8 in cell-surface stabilization and interactions with Gβ is shared across the class B GPCR family.
The human CTR has a common, naturally occurring splice variant with an insertion of 16 amino acids between Arg174 and Ser175 that has attenuation of both G-protein-dependent signalling and receptor internalization 40 . ICL1 is well resolved in the sCT-CTR-G s structure, located above the first and seventh WD40 repeat (WD1 and WD7) domains of Gβ , and within close proximity to the N-terminal α -helical domain (Nα ) of the α -subunit (Extended Data Fig. 9c ). As such, the I1+ (CTb) isoform is likely to sterically interfere with receptor-G-protein interactions, leading to the attenuation in signalling.
Comparison of class A and class B GPCR-Gα s complex
An overlay of the G-protein heterotrimer in the sCT-CTR-G s complex to that of the class A β 2 AR 4 reveals only minor differences in the conformation of the G protein between the two structures ( Fig. 5a ). While the Gα s AHD was trapped in an open conformation in the β 2 AR-G s crystal structure, it is not resolved at high resolution in the sCT-CTR-G s complex owing to its inherent flexibility in the absence of nucleotide (Extended Data Fig. 5 ).
Comparing the two receptors reveals similar locations of the intracellular helical tips of TM1-3 and 5-7 (Fig. 5b) . These transmembrane helices in class B inactive structures also overlay with class A inactive 
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receptors revealing conserved global cytoplasmic changes upon activation. Two notable differences include a helical extension of TM5 in the β 2 AR-G s complex that was not evident for the CTR, and the long helix 8 that was not observed in the β 2 AR.
At the extracellular face there are major differences in the conformation of the two receptors, reflective of their distinct activating ligands, with the class B structure that is required to accommodate a peptide, being more open (Extended Data Fig. 10 ). There are remarkable differences in TM6 and TM7, which contain kinks in both receptors, but are more pronounced in the CTR. A large shift inwards and towards TM7 in extracellular side of TM1 is also evident in the class B structure relative to the β 2 AR, with this transmembrane domain also forming an extended helical structure (three additional turns), a feature reported previously for the inactive state structure of the GCGR 7 . A notable feature is the distinct location of TM4 in the CTR relative to the β 2 AR (Fig. 5 and Extended Data Fig. 10 ). This is particularly interesting as TM4 is the predominant interface for class B GPCR dimerization, with disruption of this interface leading to attenuated G-protein signalling for all receptors that have been assessed to date, including the CTR 41, 42 .
Conclusions
The cryo-EM structure of the sCT-CTR-G s complex provides a near-atomic resolution view of a full-length class B GPCR and of an activated class B GPCR-G-protein ternary complex. Notably, the CTR is completely unmodified (with the exception of affinity tags) and is one of only a few structures of a wild-type GPCR, highlighting the potential of cryo-EM in solving structures of GPCR complexes. The structure also provides the first visualization of the binding site of the N terminus of a peptide agonist within the transmembrane bundle of a class B GPCR as well as some insight into the biological flexibility of the ternary complex. This study provides a framework to further investigate the mechanism of agonist interactions and activation of other class B GPCRs that may open up new avenues for rational design of novel therapeutics for this class of receptors.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper .  TM1   TM2  TM4   TM3   TM5   TM6   TM7   H8   TM1   TM5   TM6   TM Nb35) aligned to the G-protein complex (Gαβγ) of the β 2 AR-Gs complex (grey, G protein; green, β 2 AR). The G protein closely aligns in the two structures. There are major differences between the receptor transmembrane domains at the extracellular surface. CTR has a more kinked TM6 and a longer helix 8; the cytoplasmic face of β 2 AR TM5 is extended. b, CTR (blue) and β 2AR (green) transmembrane domains viewed from the cytoplasmic face. The intracellular transmembrane tips (with the exception of TM4) overlay, highlighting conserved movements within the intracellular face of class A and B GPCRs for G s coupling.
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METHODS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Constructs. Wild-type human calcitonin receptor (CTR) was modified to include an N-terminal Flag tag epitope and a C-terminal 8× histidine tag, both tags are removable by 3C protease cleavage (Extended Data Fig. 1 ). These constructs were generated in both mammalian and insect cell expression vectors. Insect cell expression. CTR, human Gα s short, His 6 -tagged human Gβ 1 and Gγ 2 were expressed in HighFive insect cells (Thermo Fisher Scientific) using baculovirus. Cell cultures were grown in ESF 921 serum-free media (Expression System) to a density of 4 million cells per ml and then infected with three separate baculovirus at a ratio of 1:2:2 for hCTR, Gα s and Gβ 1 γ 2 . Cultures were grown at 27 °C and harvested by centrifugation 45 h post infection. Complex purification. Cells were suspended in 20 mM HEPES pH 7.4, 50 mM NaCl, 2 mM MgCl 2 supplemented with cOmplete Protease Inhibitor Cocktail tablets (Roche). Complex formation was initiated by addition of 1 μ M salmon calcitonin, Nb35-His (10 μ g ml −1 ) and Apyrase (25 mU ml −1 , NEB); the suspension was incubated for 1 h at room temperature. Membranes were collected by centrifugation at 30,000g for 30 min, and solubilized by 0.5% (w/v) lauryl maltose neopentyl glycol (LMNG, Anatrace) supplemented with 0.03% (w/v) cholesteryl hemisuccinate (CHS, Anatrace) for 2 h at 4 °C in the presence of 100 nM salmon calcitonin and Apyrase (25 mU ml −1 , NEB). Insoluble material was removed by centrifugation at 30, 000g for 30 min and the solubilized complex was immobilised by batch binding to M1 anti-Flag affinity resin in the presence of 3 mM CaCl 2 . The resin was packed into a glass column and washed with 20 column volumes of 20 mM HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl 2 , 3 mM CaCl 2 , 100 nM sCT, 0.01% (w/v) MNG and 0.006% (w/v) CHS before bound material was eluted in buffer containing 5 mM EGTA and 0.1 mg ml −1 Flag peptide. The complex was then concentrated using an Amicon Ultra Centrifugal Filter (MWCO 100 kDa) and subjected to size-exclusion chromatography on a Superdex 200 Increase 10/300 column (GE Healthcare) pre-equilibrated with 20 mM HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl 2 , 100 nM sCT, 0.01% (w/v) MNG and 0.006% (w/v) CHS to separate complex from contaminants. Eluted fractions consisting of receptor and G-protein complex were pooled and concentrated. Final yield of purified complex was approximately 0.5 mg l −1 insect cell culture.
The stability of the CTR-G s heterotrimer complex at 4 °C was monitored by analytical SEC. SEC-purified complex was incubated on ice and 50 μ g was applied onto Superose 6 Increase 10/300 GL column at 24 h interval for a total period of 5 days. Protein was detected by measuring absorbance at 280 nm with a fluorescence detector (RF-10AXL, Shimadzu). SDS-PAGE and western blot analysis. Samples collected from each purification step were analysed by SDS-PAGE and western blot. For SDS-PAGE, precast gradient TGX gels (Bio-Rad) were used. Gels were either stained by Instant Blue (Expedeon) or immediately transferred to PVDF membrane (Bio-Rad) at 100 V for 1 h. The proteins on the PVDF membrane were probed with two primary antibodies, rabbit anti-G s C-18 antibody (cat. no. sc-383, Santa Cruz) against Gα s subunit and mouse penta-His antibody (cat. no. 34660, QIAGEN) against His tags. The membrane was washed and incubated with secondary antibodies, 680RD goat anti-mouse and 800CW goat anti-rabbit (LI-COR). Bands were imaged using an infrared imaging system (LI-COR Odyssey Imaging System). Specimen preparation and data acquisition. Concentrated sample from Superdex 200 Increase 10/300 GL column was loaded onto a Superose 6 Increase 10/300 GL column (GE Healthcare). Eluted fractions were used to prepare specimens for EM imaging using conventional negative-staining protocol 44 . Negative-stained samples were imaged at room temperature with a Tecnai T12 (FEI) electron microscope operated at 120 kV. Images were recorded at magnification of 57,000× and a defocus value of − 1 μ m on a Gatan US4000 CCM camera. All images were binned to 2 × 2 pixels to obtain a pixel size of 4.16 Å.
For cryo-EM, purified CTR-G s heterotrimer complex was diluted to 0.3 mg ml −1 with 20 mM HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl 2 , 100 nM sCT. Vitrified specimen was prepared by applying 5 μ l of protein complexes onto a glow-discharged 300 mesh copper Quantifoil R1.2/1.3 grid (Quantifoil Micro Tools), plunge-frozen in liquid ethane cooled by liquid nitrogen inside a Vitrobot Mark IV (FEI) with blotting time of 3 s and draining time of 0.5 s. Cryo-EM imaging was performed on a Titan Krios microscope operated at 300 kV (FEI) equipped with a Gatan Quantum energy filter, a Gatan K2 Summit direct electron camera (Gatan) and a Volta phase plate (FEI). A total of 2,780 recordings were taken in EFTEM nanoprobe mode, with 50 μ m C2 aperture, at a calibrated magnification of 47,170 corresponding to a magnified pixel size of 1.06 Å. Each movie comprises 50 sub frames with a total dose of 50 e − per Å 2 , exposure time between 11 and 13.75 s and a dose rate between 4 and 5 e − per pixel per second on the detector. Data acquisition was done using SerialEM software 45 and custom macros for automated single particle data acquisition with Volta phase plate at − 500 nm defocus 14 . Image processing and 3D reconstructions. Image processing and threedimensional reconstructions were performed as previously described 46 . Dose fractionated image stacks were subjected to beam-induced motion correction, globally and locally, by MotionCor2 47 . A sum of all frames, filtered according to exposure dose, in each image stack was used for further processing. CTF parameters for each micrograph were determined by CTFFIND4 48 .
Particle selection, two-dimensional classification and three-dimensional classification were performed on a binned data set with a pixel size of 2.12 Å using RELION2. Semi-automated selected 1,213,995 particle projections were subjected to reference-free two-dimensional classification to discard false-positive particles or particles categorized in poorly defined classes, resulting in 426,001 projections for further processing. An ab initio map generated by VIPER 49 was used as initial reference model for maximum-likelihood-based three-dimensional classification. One stable class with detailed features accounting for 106,838 particles was then subjected to focused refinement with a soft mask including receptor and G s protein and excluding the α -helical domain, produced the final map with global nominal resolution of 4.1 Å, and nominal resolution of 3.8 Å in the seven-transmembrane and G-protein region.
Reported resolutions are based on the gold-standard Fourier shell correlation (FSC) using the 0.143 criterion. All density maps were corrected for the modulation transfer function (MTF) of the K2 summit direct detector and then sharpened by applying temperature factor that was estimated using post-processing in RELION 18 . Local resolution was determined using ResMap with half-reconstructions as input maps. Model building. The initial template of hCTR was derived from a homology based predicted model calculated by I-TASSER 50 . Models of sCT and G s heterotrimer were adopted from the NMR structure (PDB: 2GLH) and β 2 AR-G s crystal structure (PDB: 3SN6), respectively. All models were visualized and docked into the density in Chimera 51 , followed by manual adjustment and real-space refinement using COOT 52 . Sequence assignment was guided by bulky residues such as Phe, Tyr, Trp and Arg. The final model was subjected to global refinement and minimization in real space using the module phenix.real_space_refine in PHENIX 53 . Owing to lower local resolution for the peptide, its model was omitted from the deposited structure. Model overfitting was evaluated through its refinement against one cryo-EM half map. FSC curves were calculated between the resulting model and the half map used for refinement as well as between the resulting model and the other half map for cross-validation (Extended Data Fig. 4 ). The final refinement statistics are provided in Supplementary Table 1 . Inactive homology model of hCTR. The glucagon receptor (GCGR) 4L6R X-ray structure 7 was used as the template for the CTR homology model. A GCGR/ CTR sequence alignment of the seven transmembrane domains and helix 8 was performed using the GPCRdb server 54 . This alignment was modified by closing the gap at the extracellular end of TM5 and adding residues to CTR and GCGR from their respective gene sequences to complete the alignments at the cytoplasmic end of TM5 and TM6, respectively. We used ICM (Molsoft) to remove all atoms in the 4L6R template not present in this modified GCGR sequence, and generated a CTR homology model based on the modified sequence alignment. An ICM global optimization procedure was performed using Monte Carlo conformational space sampling of side chains with hydrogen bond optimization.
Insect cell membrane preparations for radioligand and [ 35 S]GTPγS binding.
The CTR complex (CTR, Gα s and Gβ 1 γ 2 ) or CTR alone were expressed in insect HighFive cells (Expression Systems) with the same virus ratios used for the CTR complex preparation for cryo-EM. Cells were harvested approximately 42 h after the viral infection. For crude membrane preparations cells were resuspended in membrane buffer (20 mM HEPES 7.4, 50 mM NaCl, 2 mM MgCl 2 , with protease inhibitors and benzonase), dounced 20 times followed by centrifugation (10 min, 350g, 4 °C). The pellet was again resuspended in membrane buffer, dounced and clarified by centrifugation at low g. Membranes were pelleted by centrifugation (1 h, 40,000g, 4 °C), resuspended in the membrane buffer and sonicated. The protein concentration was determined using Bradford reagent (Bio-Rad).
Radioligand competition binding experiments on CTR expressed in insect cells.
Radioligand binding was performed in 20 mM HEPES pH 7.4; 100 mM NaCl; 10 mM MgCl 2 ; 0.1% BSA. First, membranes (1-2 μ g per sample) were incubated with different concentrations of sCT and Nb35 ( In our construct HA-Flag-3C-CTR-3C-8× His, the native signal peptide of the CTR (residues 2-24) was replaced with a HA signal peptide (red), Flag epitope (green) and a 3C cleavage site (yellow). The C terminus was modified with a 3C cleavage site (yellow) and a His epitope (blue). Also highlighted on the schematic are consensus glycosylation sites (purple) and class B GPCR conserved disulfide bonds. Residues highlighted in bold are the most conserved residue in each helix and represent residues x.50 for each helix according to the class B GPCR numbering. The location of the 16 amino acid insertion within ICL1 for a common splice variant of the CTR (CTRb) is shown. In addition, the locations of the truncation sites within the CTR C terminus/helix 8 assessed in this study are also highlighted.
